Respiratory impairment and COPD hospitalisation in older persons: A competing risk analysis

European Respiratory Journal

Volumn 40, Issue 1, 2012, Pages 37-44

  Vaz Fragoso, Carlos A ^a,b   Concato, John ^a,b   McAvay, Gail ^b   Van Ness, Peter H ^b   Gill, Thomas M ^b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic obstructive pulmonary disease hospitalisation; lambda; mu; sigma; Spirometry

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; RESPIRATORY AIRFLOW LIMITATION; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; SPIROMETRY;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; RISK ASSESSMENT; SPIROMETRY;

EID: 84863471807     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00128711     Document Type: Article

References (58)

1. Viegi G, Pistelli F, Sherrill DL, et al. Definition, epidemiology and natural history of COPD. Eur Respir J 2007; 30: 993-1013. (Pubitemid 351194805)
2. Albertson TE, Louie S, Chan AL. The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis. J Am Geriatr Soc 2010; 58: 570-579.
3. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
4. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007; 62: 237-241. (Pubitemid 46579804)
5. Meyer KC. Aging. Proc Am Thorac Soc 2005; 2: 433-439. (Pubitemid 43128039)
6. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages a new approach. Am J Respir Crit Care Med 2008; 177: 253-260. (Pubitemid 351198367)
7. Lung Function in Growth and Aging. Download Software and Tools. www.lungfunction.org/growinglungs/software.html Date last updated: January 13, 2011. Date last accessed: June 20, 2011.
8. Quanjer PH, Enright PL, Miller MR, et al. The need to change the method for defining mild airway obstruction. Eur Respir J 2011; 37: 720-722.
9. Celli BR, Halbert RJ, Nordyke RJ, et al. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 2005; 118: 1364-1372. (Pubitemid 41832329)
10. Vaz Fragoso CA, Concato J, McAvay G, et al. Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions. Respir Med 2010; 104: 1189-1196.
11. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988; 43: 265-267.
12. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J 1993; 6: Suppl. 16, 5-40.
13. Berry SD, Ngo L, Samelson EJ, et al. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 2010; 58: 783-787.
14. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
15. Zhang X, Zhang M-J. SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models. Comput Methods Programs Biomed 2011; 101: 87-93.
16. Fried LP, Borhani NO, Enright P, et al. The cardiovascular health study: design and rationale. Ann Epidemiol 1991; 1: 263-276.
17. Tell GS, Fried LP, Hermanson B, et al. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993; 3: 358-366. (Pubitemid 23195820)
18. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338. (Pubitemid 41079078)
19. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144: 1202-1218.
20. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968. (Pubitemid 41632054)
21. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review. JAMA 2002; 288: 1889-1897. (Pubitemid 35168145)
22. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of the FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 446-451.
23. Vaz Fragoso CA, Gill TM, McAvay G, et al. Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons. Respir Care 2011: 56; 1771-1777.
24. Vaz Fragoso CA, Gill TM, McAvay G, et al. Respiratory impairment and mortality in older persons: a novel spirometric approach. J Investig Med 2011; 59: 1089-1095.
25. Vaz Fragoso CA, Concato J, McAvay G, et al. Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores. J Am Geriatr Soc 2011; 59: 1847-1854.
26. Vaz Fragoso CA, Enright PL, McAvay G, et al. Frailty and respiratory impairment in older persons. Am J Med 2012; 125: 79-86.
27. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187. (Pubitemid 29036522)
28. Lee TA, Wilke C, Joo M, et al. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med 2009; 169: 1403-1410.
29. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 51: 289-300.
30. Peduzzi P, Concato J, Feinstein AR, et al. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995; 48: 1503-1510. (Pubitemid 26035533)
31. Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364: 897-906.
32. Vassallo R, Jensen EA, Colby TV, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124: 1199-1205. (Pubitemid 37290027)
33. Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105-111.
34. Mannino DM, Holguin F, Pavlin BI, et al. Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the first National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis 2005; 9: 613-621. (Pubitemid 40826152)
35. Dykstra BJ, Scanlon PD, Kester MM, et al. Lung volumes in 4,774 patients with obstructive lung disease. Chest 1999; 115: 68-74.
36. McKenzie DK, Butler JE, Gandevia SC. Respiratory muscle function and activation in chronic obstructive pulmonary disease. J Appl Physiol 2009; 107: 621-629.
37. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946. (Pubitemid 38807371)
38. Burgel P-R, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009; 135: 975-982.
39. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976; 294: 1071-1075.
40. Lee HM, Le H, Lee BT, et al. Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality. Eur Respir J 2010; 36: 1002-1006.
41. Hannink JD, van Helvoort HA, Dekhuijzen PN, et al. Heart failure and COPD: partners in crime? Respirology 2010; 15: 895-901.
42. Gill TM, Allore HG, Gahbauer EA, et al. Change in disability after hospitalization or restricted activity in older persons. JAMA 2010; 304: 1919-1928.
43. Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300: 1439-1450.
44. Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300: 2407-2416.
45. Stephenson A, Seitz D, Bell CM, et al. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study. Arch Intern Med 2011; 171: 914-920.
46. Taylor DR. The beta-agonist saga and its clinical relevance: on and on it goes. Am J Respir Crit Care Med 2009; 179: 976-978.
47. Dransfield MT, Bailey WC. COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med 2006; 27: 463-471. (Pubitemid 44118532)
48. Enright PL, McClelland RL, Newman AB, et al. Underdiagnosis and undertreatment of asthma in the elderly. Chest 1999; 116: 603-613. (Pubitemid 29428473)
49. Patel IS, Vlahos I, Wilkinson TMA, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 400-407. (Pubitemid 39214614)
50. Seitz AE, Olivier KN, Steiner CA, et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest 2010; 138: 944-949.
51. Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 2005; 128: 1239-1244. (Pubitemid 41324401)
52. Slavin RG, Haselkorn T, Lee JH, et al. Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. Ann Allergy Asthma Immunol 2006; 96: 406-414.
53. Di Bari M, Chiarlone M, Matteuzzi D, et al. Thoracic kyphosis and ventilatory dysfunction in unselected older persons: an epidemiological study in Dicomano, Italy. J Am Geriatr Soc 2004; 52: 909-915. (Pubitemid 38789062)
54. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
55. Georgiopoulou VV, Kalogeropoulos AP, Psaty BM, et al. Lung function and risk for heart failure among older adults: the Health ABC Study. Am J Med 2011; 124: 334-341.
56. Chan ED, Welsh CH. Geriatric respiratory medicine. Chest 1998; 114: 1704-1733. (Pubitemid 128487495)
57. Glady CA, Aaron SD, Lunau M, et al. Spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory. Chest 2003; 123: 1939-1946. (Pubitemid 36706715)
58. Aaron SD, Dales RE, Cardinal P. How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 1999; 115: 869-873. (Pubitemid 29129975)